Marpai, Inc. (NASDAQ:MRAI – Get Rating) was the target of a large decline in short interest during the month of December. As of December 15th, there was short interest totalling 50,200 shares, a decline of 26.3% from the November 30th total of 68,100 shares. Based on an average daily trading volume, of 20,800 shares, the days-to-cover ratio is currently 2.4 days. Currently, 0.5% of the shares of the stock are short sold.
Marpai Stock Down 7.7 %
Marpai stock opened at $0.72 on Monday. The firm has a market capitalization of $15.08 million, a PE ratio of -0.58 and a beta of 0.40. Marpai has a 52 week low of $0.69 and a 52 week high of $4.57. The firm's 50-day simple moving average is $0.92 and its 200 day simple moving average is $0.95.
Get
Marpai alerts:
Marpai (NASDAQ:MRAI – Get Rating) last announced its quarterly earnings results on Wednesday, November 9th. The company reported ($0.28) earnings per share (EPS) for the quarter. The business had revenue of $4.94 million during the quarter. Marpai had a negative net margin of 104.66% and a negative return on equity of 108.51%.
Institutional Investors Weigh In On Marpai
A hedge fund recently bought a new stake in Marpai stock. Jane Street Group LLC acquired a new stake in Marpai, Inc. (NASDAQ:MRAI – Get Rating) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 24,490 shares of the company's stock, valued at approximately $25,000. Jane Street Group LLC owned approximately 0.12% of Marpai as of its most recent SEC filing. 35.90% of the stock is owned by institutional investors and hedge funds.
Marpai Company Profile
(Get Rating)
Marpai, Inc, a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, health savings account administration, and cost containment services.
See Also
- Get a free copy of the StockNews.com research report on Marpai (MRAI)
- MarketBeat: Week in Review 12/26 – 12/30
- The Dogs Of Tech: It's Time For A Bite Of These Stocks
- Does This Acquisition Make Microsoft a Bear Market Buy?
- Should You Warm up to Generac Stock for the Winter?
- Is Kintara Therapeutics A Hidden Gem?
Receive News & Ratings for Marpai Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marpai and related companies with MarketBeat.com's FREE daily email newsletter.
